(52 days)
No
The description focuses on image transfer, storage, and display, with no mention of AI or ML algorithms for image processing or analysis.
No
The device is described as software for the transfer, storage, display, and processing of medical images and data, rather than directly diagnosing, treating, or preventing a disease or condition.
No
The device is described as software for transferring, storing, accessing, displaying, and processing medical images and data, rather than for diagnosing conditions or making diagnostic interpretations. It facilitates the management of diagnostic data but does not perform the diagnosis itself.
Yes
The device description explicitly states "Syntermed Live™ is an Internet based system used to securely access, transfer, display, archive, and process medical images and data". It focuses on the software functionalities of transmission, retrieval, display, archiving, and processing of digital medical data. While it interacts with external sources of medical images and data, the device itself, as described, is the software system.
Based on the provided information, it is unlikely that this device is an IVD (In Vitro Diagnostic). Here's why:
- Intended Use: The primary intended use is the transfer, storage, access, display, and processing of medical images and data. This focuses on managing and presenting existing medical data, not on performing a diagnostic test on a biological sample.
- Device Description: The description reinforces the focus on accessing, transferring, displaying, archiving, and processing medical images and data. It describes a system for handling output data files, not for analyzing biological specimens.
- Input Imaging Modality: The input is SPECT and PET images, which are generated from imaging procedures performed on the patient, not from in vitro analysis of biological samples.
- Lack of Biological Sample Analysis: There is no mention of analyzing blood, urine, tissue, or any other biological sample, which is a core characteristic of an IVD.
- Focus on Image Processing and Display: While image processing is mentioned, it's in the context of displaying and reviewing the images, not performing a diagnostic test based on the image data itself.
- Validation Method: The validation described involves comparing visual interpretations of images, which aligns with a medical image display and processing system, not an IVD.
In summary, the Syntermed Live™ software program appears to be a medical image management and display system, not a device that performs a diagnostic test on a biological sample. Therefore, it does not fit the definition of an In Vitro Diagnostic device.
N/A
Intended Use / Indications for Use
The Syntermed Live™ software program should be used for the transfer of medical images and data to a secure server for storage where it can subsequently be accessed, displayed, and processed on any PC connected to the Internet using either proprietary software applications, a DICOM Viewer, or a Web Browser.
Product codes
LLZ
Device Description
Syntermed Live™ is an Internet based system used to securely access, transfer, display, archive, and process medical images and data generated from a hospital or clinic. The Syntermed Live™ project is involved with the transmission and retrieval of output data files from either Syntermed proprietary applications, DICOM image files, or other medical digital data files to a Syntermed web server so that they can be archived and delivered to Syntermed customers for remote storage and review.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The validation conducted in this submission is listed in Item H, Testing & Validation and this analysis compared the visual interpretation of 30 patient studies using the previous analysis to visual interpretation of the Syntermed Live generated images.
The safety of this program has been determined through the various stages of software development which included the initial design, coding, debugging, testing, and validation. The effectiveness of the program has been established in in-house testing and clinical validation studies. Specific details and results concerning the validation of the . Syntermed Live™ program are listed in Item H, Testing & Validation.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
INTEGRADWeb MPR/MIP™ Reference #: K042313
Reference Device(s)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
ITEM I
MAR 0 2 2007
510(k) SUMMARY
Safety and Effectiveness
1. Medical Device Establishment:
Syntermed, Inc. Registration No. 1066019 Owner Operator I.D. 9041128 Voice &FAX: (714) 281-1256 Contact person: Kenneth Van Train Email: vantrain@syntermed.com Date Summary Prepared: August 3, 2004
2. Medical Device:
The Syntermed Live™ software program should be used for the transfer of medical images and data to a secure server for storage where it can subsequently be accessed, displayed, and processed on any PC connected to the Internet using either proprietary software applications, a DICOM Viewer, or a Web Browser.
3. Medical Device Equivalence:
INTEGRADWeb MPR/MIP™ Reference #: K042313
4. Device Description:
Syntermed Live™ is an Internet based system used to securely access, transfer, display, archive, and process medical images and data generated from a hospital or clinic. The Syntermed Live™ project is involved with the transmission and retrieval of output data files from either Syntermed proprietary applications, DICOM image files, or other medical digital data files to a Syntermed web server so that they can be archived and delivered to Syntermed customers for remote storage and review.
5. Intended Use and Potential Adverse Effect on Health:
The intended use of this program was to provide the physician with a program that would allow them to transfer medical images and data to a secure server for storage where it can subsequently be accessed, displayed, and processed on any PC connected to the Internet using either proprietary software applications, a DICOM Viewer, or a Web Browser. This
1
program serves merely as a display program to aid in the visual interpretation of a patient's study. This program is used as only a tool to display the patient's medical images. The physician should integrate all of the patients' clinical and diagnostic information prior to making his final interpretation. The expected accuracy of the program can be found in our initial 510(k) submission of the Emory Cardiac Toolbox, K980914. The validation conducted in this submission is listed in Item H, Testing & Validation and this analysis compared the visual interpretation of 30 patient studies using the previous analysis to visual interpretation of the Syntermed Live generated images. The physician should be aware of the accuracy of the initial program when integrating the quantitative results for his final interpretation. Therefore, this program has no direct adverse effect on health since the results represent only a part of the information, which the physician will utilize for his final interpretation. The final responsibility for interpretation of the study lies with the physician.
6. Marketing History:
There have been several medical device display programs for SPECT and PET marketed in the past which perform similar functions to those performed by the Syntermed Live™ program. The Emory Cardiac Toolbox and NeuroQ are the medical devices which produce the images and quantitative data and Syntermed has filed 510(k) Pre-Market Notifications for these applications (Emory Cardiac Toolbox v2.0, v2.1, v2.6, and NeuroQ v1.0). These programs are all used for the purpose of displaying SPECT and PET tomographic slices and quantitative output which are interpreted by the physician. Syntermed Live™ provides remote access to the data and the ability to display the output of the Syntermed applications using either the applications or Internet Browsers and we believe it is substantially equivalent to the INTEGRADWeb MPR/MIP™ program. To our knowledge there have been no safety problems with the INTEGRADWeb MPR/MIP™ program which has been in the marketplace since September 9, 2004.
7. Conclusions:
The safety of this program has been determined through the various stages of software development which included the initial design, coding, debugging, testing, and validation. The effectiveness of the program has been established in in-house testing and clinical validation studies. Specific details and results concerning the validation of the . Syntermed Live™ program are listed in Item H, Testing & Validation. - We contend that the method employed for the development and the final in-house validation results of this medical display software program, . Syntermed Live™, have proven its safety and effectiveness. In our opinion the . Syntermed Live™ program is substantially equivalent to the INTEGRADWeb MPR/MIPTM program which has been cleared for marketing. The . Syntermed Live™ program is intended for the same purpose and raises no new issues of safety or effectiveness.
2
Image /page/2/Picture/0 description: The image shows a circular logo for the U.S. Department of Health & Human Services. The logo features the department's name encircling an abstract symbol. The symbol appears to be a stylized representation of a human figure or a bird in flight, composed of three curved lines.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration 9200 Corporate Blvd. Rockville MD 20850
Mr. Kenneth F. Van Train President Syntermed 245 Owens Drive ANAHEIM CA 92808
MAR 0 2 2007
Re: K070089
Trade/Device Name: Syntermed Live™ Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: January 6, 2007 Received: January 15, 2007
Dear Mr. Van Train:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Image /page/2/Picture/10 description: The image is a black and white circular logo or emblem. The text "1906-2006" is at the top of the circle. The letters "PA" are in the center of the circle in a bold, sans-serif font. The word "Centennial" is below the letters "PA". Three stars are below the word "Centennial".
oting Public 9
3
Page 2 --
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act that I Drederal statutes and regulations administered by other Federal agencies. You must or any I with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) I mis letter will and in your e FDA finding of substantial equivalence of your device to a legally prematication of thesults in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 21 CFR 876.xxx | (Gastroenterology/Renal/Urology | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 894.xxx | (Radiology) | 240-276-0120 |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under (21 Cl 1 . For 60 .. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . toll-free number (800) 638-2041 or (240) 276-3150
or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html.
Sincerely yours,
Nancy C. Hogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) NUMBER (IF KNOWN): _ KNOWN): _ K (0 7 0 € 8 )
DEVICE NAME: Syntermed Live TM
INDICATION FOR USE:
The Syntermed Live™ software program should be used for the transfer of medical images and data to a secure server for storage where it can subsequently be accessed, displayed, and processed on any PC connected to the Internet using either proprietary software applications, a DICOM Viewer, or a Web Browser.
(Please do not write below this line - Continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use (Per 21 CFR 801.109)
OR
Over-the-Counter Use
Daniel A. Bergmann
(Optional format 1-2-96)
(Division Sign-Off)
A
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number K070089
(Optional Format 1-2-96)